Abstract:Background
Neuroinflammation plays an important role in the pathogenesis of glaucoma. Tumor necrosis factor-alpha (TNF-α) is a major pro-inflammatory cytokine released from activated retinal glial cells in glaucoma. Here, we investigated how TNF-α induces retinal ganglion cell (RGC) hyperexcitability and injury.
Methods
Whole-cell patch-clamp techniques were performed to explore changes in spontaneous firing and evoked action potentials, and Na+ cu… Show more
“…Activated Müller cells could induce microglia activation and the interaction of Müller cells and microglia aggravated retinal inflammatory response, which contributed to RGC injury in COH retina (Hu et al, 2021). Based on the present results and our previous study (Cheng et al, 2021; Hu et al, 2021; Xu et al, 2020), we speculate that at the early stage of IOP elevation, inhibition of the reverse signaling could rescue GLAST downregulation and attenuate Müller cell gliosis, thus relieving the activation of retinal glial cells and reducing retinal inflammatory response, which indirectly contribute to reduction of RGC apoptosis. On the other hand, inhibition of the forward signaling in RGCs may directly attenuate RGC apoptosis (Xu et al, 2020).…”
Deficiency of glutamate transporter GLAST in Müller cells may be culpable for excessive extracellular glutamate, which involves in retinal ganglion cell (RGC) damage in glaucoma. We elucidated how GLAST was regulated in rat chronic ocular hypertension (COH) model. Western blot and whole-cell patch-clamp recordings showed that GLAST proteins and GLAST-mediated current densities in Müller cells were downregulated at the early stages of COH. In normal rats, intravitreal injection of the ephrinA3 activator EphA4-Fc mimicked the changes of GLAST in COH retinas. In purified cultured Müller cells, EphA4-Fc treatment reduced GLAST expression at mRNA and protein levels, which was reversed by the tyrosine kinase inhibitor PP2 or transfection with ephrinA3-siRNA (Si-EFNA3), suggesting that EphA4/ephrinA3 reverse signaling mediated GLAST downregulation.EphA4/ephrinA3 reverse signaling-induced GLAST downregulation was mediated by inhibiting PI3K/Akt/NF-κB pathways since EphA4-Fc treatment of cultured Müller cells reduced the levels of p-Akt/Akt and NF-κB p65, which were reversed by transfecting Si-EFNA3. In Müller cells with ephrinA3 knockdown, the PI3K inhibitor LY294002 still decreased the protein levels of NF-κB p65 in the presence of EphA4-Fc, and the mRNA levels of GLAST were reduced by LY294002 and the NF-κB inhibitor SN50, respectively. Pre-injection of the PI3K/Akt pathway activator 740 Y-P reversed the GLAST downregulation in COH retinas. Western blot and TUNEL staining showed that transfecting of Si-EFNA3 reduced Müller cell gliosis and RGC apoptosis in COH retinas. Our results suggest that activated EphA4/ephrinA3 reverse signaling induces GLAST downregulation in Müller cells via inhibiting PI3K/Akt/NF-κB pathways, thus contributing to RGC damage in glaucoma.
“…Activated Müller cells could induce microglia activation and the interaction of Müller cells and microglia aggravated retinal inflammatory response, which contributed to RGC injury in COH retina (Hu et al, 2021). Based on the present results and our previous study (Cheng et al, 2021; Hu et al, 2021; Xu et al, 2020), we speculate that at the early stage of IOP elevation, inhibition of the reverse signaling could rescue GLAST downregulation and attenuate Müller cell gliosis, thus relieving the activation of retinal glial cells and reducing retinal inflammatory response, which indirectly contribute to reduction of RGC apoptosis. On the other hand, inhibition of the forward signaling in RGCs may directly attenuate RGC apoptosis (Xu et al, 2020).…”
Deficiency of glutamate transporter GLAST in Müller cells may be culpable for excessive extracellular glutamate, which involves in retinal ganglion cell (RGC) damage in glaucoma. We elucidated how GLAST was regulated in rat chronic ocular hypertension (COH) model. Western blot and whole-cell patch-clamp recordings showed that GLAST proteins and GLAST-mediated current densities in Müller cells were downregulated at the early stages of COH. In normal rats, intravitreal injection of the ephrinA3 activator EphA4-Fc mimicked the changes of GLAST in COH retinas. In purified cultured Müller cells, EphA4-Fc treatment reduced GLAST expression at mRNA and protein levels, which was reversed by the tyrosine kinase inhibitor PP2 or transfection with ephrinA3-siRNA (Si-EFNA3), suggesting that EphA4/ephrinA3 reverse signaling mediated GLAST downregulation.EphA4/ephrinA3 reverse signaling-induced GLAST downregulation was mediated by inhibiting PI3K/Akt/NF-κB pathways since EphA4-Fc treatment of cultured Müller cells reduced the levels of p-Akt/Akt and NF-κB p65, which were reversed by transfecting Si-EFNA3. In Müller cells with ephrinA3 knockdown, the PI3K inhibitor LY294002 still decreased the protein levels of NF-κB p65 in the presence of EphA4-Fc, and the mRNA levels of GLAST were reduced by LY294002 and the NF-κB inhibitor SN50, respectively. Pre-injection of the PI3K/Akt pathway activator 740 Y-P reversed the GLAST downregulation in COH retinas. Western blot and TUNEL staining showed that transfecting of Si-EFNA3 reduced Müller cell gliosis and RGC apoptosis in COH retinas. Our results suggest that activated EphA4/ephrinA3 reverse signaling induces GLAST downregulation in Müller cells via inhibiting PI3K/Akt/NF-κB pathways, thus contributing to RGC damage in glaucoma.
“…2; P = 0.0001, one‐way ANOVA with Holm–Šídák's multiple comparisons test; n = 5−6, N = 5−6). Pre‐treatment with R7050, an inhibitor of TNFR1 signalling (Cheng et al., 2021), attenuated the TNFα‐mediated rise in [Ca 2+ ] i in DRG neurons isolated from wild‐type (WT) mice ( P = 0.035, one‐way ANOVA with Holm–Šídák's multiple comparisons test; n = 5, N = 5; Fig. 2) and reduced the proportion of TNFα‐sensitive neurons ( P = 0.004, one‐way ANOVA with Holm–Šídák's multiple comparisons test; n = 5, N = 5; Fig.…”
“…Ca 2+ acts as second messenger to activate downstream signaling pathways leading to RGCs apoptosis [73]. TNF-α and TNF-α receptor 1 signaling could also induce RGC hyper-excitability by upregulating Na + channels, which contribute to RGCs apoptosis in glaucoma [74]. In our previous study, we cultured RGCs from adult rats in a medium containing neurotrophic factors [12].…”
Section: Current Strategy Of Epo For Optic Nerve Protection and Repairmentioning
Erythropoietin (EPO) is known as a hormone for erythropoiesis in response to anemia and hypoxia. However, the effect of EPO is not only limited to hematopoietic tissue. Several studies have highlighted the neuroprotective function of EPO in extra-hematopoietic tissues, especially the retina. EPO could interact with its heterodimer receptor (EPOR/βcR) to exert its anti-apoptosis, anti-inflammation and anti-oxidation effects in preventing retinal ganglion cells death through different intracellular signaling pathways. In this review, we summarized the available pre-clinical studies of EPO in treating glaucomatous optic neuropathy, optic neuritis, non-arteritic anterior ischemic optic neuropathy and traumatic optic neuropathy. In addition, we explore the future strategies of EPO for optic nerve protection and repair, including advances in EPO derivates, and EPO deliveries. These strategies will lead to a new chapter in the treatment of optic neuropathy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.